NPR News: FDA Faulted For Lapses In Orphan Drug Program

FDA Faulted For Lapses In Orphan Drug Program
The Government Accountability Office found breakdowns in the way the Food and Drug Administration evaluates drugs for rare diseases. The analysis came after an investigation by Kaiser Health News.